CAROLINA, Puerto Rico, May 14, 2024
/PRNewswire/ -- CorePlus www.corepluspr.com, a precision pathology
organization, announced today that it is the first laboratory in
the world to operationalize the Techcyte AI algorithm and quality
control workflow for cytology-based cervical cancer screening.
After more than two years of clinical collaboration with Techcyte,
we have achieved the level of precision and accuracy necessary to
deploy this tool for use with our patients to provide 100% quality
control of all Pap tests, which goes well beyond the regulatory
mandates.
We are fortunate to have been able to include Puerto Rican women
in the validation of the algorithm. Ethnic diversity is a key to
eliminating potential algorithmic bias. Including this subset of
the population, ensures that Hispanic women will be well
represented. This is important as Hispanics are becoming a
significant percentage of the US population." said Mariano de Socarraz, Founder and CEO of
CorePlus.
Puerto Rican women faced an increase in the incidence of
cervical cancer rate from 9.2 to 13 cases per 100,000 between 2001
to 20171. Early detection is paramount to provide
initial therapeutic intervention and ensure better quality of life
and impact healthcare cost.
Juan C. Santa-Rosario, M.D.,
CorePlus' Chief Medical Officer states, "Our validation study
included digitization of more than 1,500 cases scanned on the
Epredia P1000 with water immersion at different modalities and was
conducted by Dr. María del Mar Rivera-Rolón, our Board-Certified
Cytopathologist. Now we will be able to review 100% of Pap tests
processed at our laboratory using the Techcyte AI-assisted tool
with the intent of providing more accurate results and promoting
patient safety."
"CorePlus is one of the most innovative organizations in the
world at implementing digital pathology solutions. We are thrilled
they will be using our AI-based cervical cytology software to have
a real impact on the health of women in Puerto Rico and throughout the world. We
appreciate their collaboration and shared mission to make a
positive impact for lab professionals and the patients they serve."
said Ben Cahoon, CEO of
Techcyte.
CorePlus is committed to deploying new and disruptive
technologies that will benefit our patients, physicians, and the
healthcare ecosystem at large.
About CorePlus
CorePlus Servicios Clínicos y Patológicos, LLC, a precision
pathology organization, a leader in the transformation of pathology
to digital pathology and the use of Artificial Intelligence (AI)
algorithms since 2020. CorePlus is a high complexity CLIA certified
laboratory with facilities in Carolina and Ponce, Puerto Rico. CorePlus has implemented and
validated the AI-powered solutions pursuant to CLIA laboratory
developed test (LDT) regulations and College of American Pathology
(CAP) guidelines. The CorePlus Team of Board-certified pathologists
became the first in the United
States and the Americas to operationalize Ibex's Galen
Prostate solution June of 2020.
Visit www.corepluspr.com for more information.
About Techcyte
Founded in 2013, Techcyte is transforming the practice of
pathology with a unified pathology platform that digitizes lab
workflows and offers AI tools that improve the efficiency and
accuracy of diagnostic testing.
Our mission is to positively impact the health of humans,
animals, and the environment through the use of artificial
intelligence.
We do that by partnering with best-in-class labs, whole slide
scanner manufacturers, AI vendors, diagnostic companies, hardware
manufacturers, and solution providers. Together, we aim to deliver
a unified clinical and anatomic pathology platform to labs and
clinics around the world.
Visit www.techcyte.com for more information.
About Epredia
Epredia, a global leader in precision cancer diagnostics and
subsidiary of PHC Holdings Corporation (TSE: 6523) offers a unique
array of end-to-end instruments for pathology workflows including
tissue processors, microtomes, embedding stations, and a range of
3DHistech developed whole slide scanners from the single slide
Pannoramic Desk II to the Pannoramic 1000 scanner. These scanners
offer a single slide to 1000 slide capacity and a throughput of up
to 85 slides per hour, including overnight scanning.
Visit www.epredia.com for more information.
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809611/
Ortiz, A.P., Ortiz-Ortiz, K.J., Colon-Lopez, V., Tortolero-Luna,
G., Torres-Cintron, C.R.,Wu, C.F., Deshmukh, A.A., 2021. Incidence
of Cervical Cancer in Puerto Rico,
2001-2017. In JAMA Oncology (Vol. 7, Issue 3, pp. 456–458).
American Medical Association. 10.1001/jamaoncol.2020.7488.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/coreplus-announces-the-deployment-of-artificial-intelligence-algorithm-for-100-qc-of-pap-tests-302143534.html
SOURCE CorePlus Servicios Clinicos y Patologicos, LLC